ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 221 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,088,834 | -18.8% | 199,786 | 0.0% | 0.07% | -23.2% |
Q2 2023 | $1,340,564 | -25.1% | 199,786 | -1.4% | 0.10% | -31.2% |
Q1 2023 | $1,789,938 | +28.9% | 202,711 | +11.6% | 0.14% | +2.2% |
Q4 2022 | $1,388,272 | +7.1% | 181,711 | -0.2% | 0.14% | 0.0% |
Q3 2022 | $1,296,000 | -12.0% | 182,161 | 0.0% | 0.14% | -2.9% |
Q2 2022 | $1,473,000 | -41.6% | 182,161 | +0.2% | 0.14% | -34.4% |
Q1 2022 | $2,522,000 | -49.4% | 181,711 | +2.4% | 0.21% | -49.4% |
Q4 2021 | $4,981,000 | -18.4% | 177,536 | -1.1% | 0.42% | -39.2% |
Q3 2021 | $6,102,000 | -16.8% | 179,536 | 0.0% | 0.69% | -21.8% |
Q2 2021 | $7,335,000 | -2.3% | 179,536 | -3.8% | 0.88% | -26.6% |
Q1 2021 | $7,509,000 | -40.1% | 186,536 | -12.0% | 1.20% | -54.1% |
Q4 2020 | $12,531,000 | -4.3% | 211,936 | -21.3% | 2.62% | -18.6% |
Q3 2020 | $13,090,000 | -43.5% | 269,186 | -43.8% | 3.22% | -51.9% |
Q2 2020 | $23,173,000 | +55.3% | 478,979 | -10.8% | 6.69% | +31.2% |
Q1 2020 | $14,920,000 | +275.3% | 537,095 | +304.1% | 5.10% | +154.1% |
Q4 2019 | $3,976,000 | – | 132,916 | – | 2.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
Triatomic Management LP | 102,889 | $560,745 | 0.39% |